Company: INGN
Filing Date: 2025-01-27
Form Type: 8-K
Source: 0000950170-25-008986
Chunk: 1

Company: Inogen Inc
Filing Date: 2025-01-27
Form: 8-K
Item: Item 1.01
Chunk 1
---
 and to use its reasonable best efforts to have the registration statement declared effective at the earliest possible date, but no later than the earlier of (i) the 75th calendar day following the initial filing date of the registration statement if the SEC notifies the Company that it will review the registration statement and (ii) the fifth business day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the registration statement will not be reviewed or will not be subject to further review, subject to certain exceptions if timely effectiveness is not achieved. Subject to certain restrictions, customary information rights and preemptive rights will be granted to the Investor under the Registration Rights Agreement for so long as the Investor owns at least 7.5% of the Company’s outstanding Common Stock.

Pursuant to the Registration Rights Agreement, the Company will also agree to, among other things, indemnify the Investor, each person who controls the Investor, the members, directors, officers, partners, employees, members, managers, agents, representatives and advisors of the Investor from certain liabilities and pay all fees and expenses incident to the Company’s obligations under the Registration Rights Agreement.

The securities to be issued and sold to the Investor under the Purchase Agreement will not be registered under the Securities Act of 1933, as amended (the “ Securities Act”) in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation S promulgated thereunder, or under any state securities laws. The Company relied on this exemption from registration based in part on representations made by the Investor. The securities may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. Neither this Current Report on Form 8-K, nor the exhibits attached hereto, is an offer to sell or the solicitation of an offer to buy the securities described herein.

The foregoing summaries of the Collaboration Agreement, the Purchase Agreement and the Registration Rights Agreement do not purport to be complete and are qualified in their entirety by reference to the Collaboration Agreement, the Purchase Agreement and the form of Registration Rights Agreement, copies of which are filed as Exhibits 10.1, 10.2 and 10.3 to this Current Report on Form 8-K, respectively, and are incorporated by reference herein.

Item 3.02. Unregistered Sales of Equity Securities.

To the extent required by Form 8-K, the disclosures in Item 1.01 above are incorporated herein by reference.

Item